Uppaluri, Ravindra

Targeting EZH2 enhances antigen presentation, antitumor immunity, and circumvents anti-PD-1 resistance in head and neck cancer

Zhou, L., Mudianto, T., Ma, X., Riley, R., & Uppaluri, R. (2020) · Clinical Cancer Research

Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses

Cited by 269

Graph deep learning for the characterization of tumour microenvironments from spatial protein profiles in tissue specimens

Wu, Z., Trevino, A. E., Wu, E., Swanson, K., Kim, H. J., D’Angio, H. B., Preska, R., Charville, G. W., Dalerba, P. D., Egloff, A. M., et al. (2022) · Nature Biomedical Engineering

Single-cell and spatial transcriptomicsAI in cancer detection

Cited by 154

Neoadjuvant PD-1 Immune Checkpoint Blockade Reverses Functional Immunodominance among Tumor Antigen–Specific T Cells

Friedman, J., Moore, E. C., Zolkind, P., Robbins, Y., Clavijo, P. E., Sun, L., Greene, S., Morisada, M. V., Mydlarz, W. K., Schmitt, N., et al. (2020) · Clinical Cancer Research

Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses

Cited by 88

Yap1 Mediates Trametinib Resistance in Head and Neck Squamous Cell Carcinomas

Mudianto, T., Campbell, K. M., Webb, J., Zolkind, P., Skidmore, Z. L., Riley, R., Barnell, E. K., Ozgenc, I., Giri, T., Dunn, G. P., et al. (2021) · Clinical Cancer Research

Hippo pathway signaling and YAP/TAZMelanoma and MAPK Pathways

Cited by 33